Treatment of Patients with Heart Failure with HFrEF and HFpEF

To participate in this activity, please:

Course Credit:

1 AAFP Hour
1 AMA PRA Category 1 CreditTM
1 CA-BRN Contact Hour

Dates:

Opens: 2023-05-04
Closes: 2023-06-04

Target Audience:

Accreditation

In support of improving patient care, Annenberg Center for Health Sciences at Eisenhower (Annenberg Center) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The AAFP has reviewed Grand Rounds 2023, and deemed it acceptable for AAFP credit. Term of approval is from 01/05/2023 to 12/21/2023. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Provider is approved by the California Board of Registered Nursing, Provider #13664, for 1 contact hour.
To receive credit for education contact hours outside of the state of California, please check with your state board of registered nursing for reciprocity.
Annenberg Center for Health Sciences

All members of the Eisenhower Health Education Committee have no relevant financial relationships to disclose

All of the financial relationships listed for these individuals have been mitigated.

    Presenting Faculty

  • Barry H. Greenberg, MD

    Professor of Medicine
    Director, Advanced Heart Failure Treatment Program
    University of California, San Diego
    La Jolla, California

Downloads

This course has no downloads at this time.

Learning Objectives

  • Discuss guideline recommendations for treating heart failure
  • Describe guideline directed therapies for treating patients with HFrEF
  • Describe guideline directed therapies for treating patients with HFpEF

Faculty Disclosures

Barry H. Greenberg, MD

Advisory Board: Bayer
Consultant: ACI, Axon, AstraZeneca, Boehringer Ingelheim, Cellular Dynamics, Cytokinetics, EBR, Faraday